Intercept Pharmaceuticals... (ICPT)
NASDAQ: ICPT
· Real-Time Price · USD
19.00
0.04 (0.21%)
At close: Nov 07, 2023, 10:00 PM
Intercept Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.76M | -5.83M | -31.88M | -17M | -133.05M | -7.53M | -17.28M | -36.28M | -3.63M | -11.09M | -40.42M |
Depreciation & Amortization | 97K | 90K | 89K | 101K | 80K | 36K | 375K | 421K | 808K | 879K | 870K |
Stock-Based Compensation | 6.65M | 6.26M | 5.86M | 5.23M | 5.79M | 4.15M | 6.72M | 8.4M | 8.62M | 8.45M | 8.42M |
Other Working Capital | -3.82M | 1.2M | 19.02M | 753K | -11.34M | 13M | -5.86M | -2.16M | 710K | 2.83M | -6.74M |
Other Non-Cash Items | 584K | 716K | -1.59M | -3.07M | 96.3M | 5.01M | 2.1M | 12.22M | -5.38M | 10.04M | 10.46M |
Deferred Income Tax | 1.15M | -2.43M | n/a | n/a | n/a | 2.58M | 750K | 1.33M | -15.45M | 922K | 1.42M |
Change in Working Capital | 10.96M | -22.12M | -24.08M | 9.93M | 14.29M | 10.48M | -12.79M | 19.08M | 4.23M | -3.75M | -33.98M |
Operating Cash Flow | 16.69M | -23.3M | -51.6M | -4.81M | -16.59M | 14.74M | -20.12M | 3.85M | 4.64M | 4.52M | -54.65M |
Capital Expenditures | -13K | -98K | n/a | 297K | -334K | -524K | -7K | n/a | n/a | -20K | -377K |
Cash Acquisitions | -59.79M | n/a | n/a | 55.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -34.89M | -90.66M | -55.63M | -151.67M | -161.65M | -96.63M | -142.79M | -71.02M | -191.03M | -36.87M | -50.53M |
Sales Maturities Of Investments | 94.68M | 187.63M | 121.18M | 96.44M | 130.33M | 96.58M | 128.58M | 86.35M | 106.77M | 85.21M | 142.25M |
Other Investing Acitivies | 59.79M | 74K | -6.23M | -55.23M | 363.23M | -54K | -14.21M | 15.33M | -84.26M | 48.34M | 91.72M |
Investing Cash Flow | 59.77M | 96.95M | 59.32M | -54.94M | 331.58M | -578K | -14.22M | 15.33M | -84.26M | 48.31M | 91.34M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -33K | -49K | -269K | -77K | -135K | -27K | -318K | -148K | -76.09M | -242K | -1.08M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -110M | -43K | -254K | -5.67M | -257.4M | -3.92M | -318K | -965K | 3.39M | -224K | -1.08M |
Financial Cash Flow | -110M | -43K | -254K | -5.67M | -257.4M | -3.92M | -318K | -965K | 3.39M | -224K | -1.08M |
Net Cash Flow | -33.7M | 74.34M | 7.16M | -64.32M | 53.17M | 7.53M | -34.94M | 17.44M | -76.71M | 53.3M | 34.73M |
Free Cash Flow | 16.67M | -23.4M | -51.6M | -4.51M | -16.92M | 14.21M | -20.13M | 3.85M | 4.64M | 4.5M | -55.03M |